EUVIMEDEUVIMED entdecken
Crossref

Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members

Judith A Groeneweg, Aditya Bhonsale, Cynthia A James, Anneline S te Riele, Dennis Dooijes, Crystal Tichnell, Brittney Murray, Ans C P Wiesfeld, Abhishek C Sawant, Bina Kassamali, Douwe E Atsma, Paul G Volders und 16 weitere

Circulation: Cardiovascular Genetics · 2015-06 · 8 (3) · 437-446

DOI: 10.1161/circgenetics.114.001003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Genetics, 2015-06. Verfasst von Judith A Groeneweg und 27 weiteren Autor:innen. Die Arbeit wurde bisher 456-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background— Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a progressive cardiomyopathy. We aimed to define long-term outcome in a transatlantic cohort of 1001 individuals. Methods and Results— Clinical and genetic characteristics and follow-up data of ARVD/C index-patients (n=439, fulfilling of 2010 criteria in all) and family members (n=562) were assessed. Mutations were identified in 276 index-patients (63%). Index-patients presented predominantly with sustained ventricular arrhythmias (268; 61%). During a median follow-up of 7 years, 301 of the 416 index-patients presenting alive (72%) experienced sustained ventricular arrhythmias. Sudden cardiac death during follow-up occurred more frequently among index-patients without an implantable cardioverter-defibrillator (10/63, 16% versus 2/335, 0.6%). Overall, cardiac mortality and the need for cardiac transplantation were low (6% and 4%, respectively). Clinical characteristics and outcomes were similar in index-patients with and without mutations, as well as in those with familial and nonfamilial ARVD/C. ARVD/C was diagnosed in 207 family members (37%). Symptoms at first evaluation correlated with disease expression. Family members with mutations were more likely to meet Task Force Criteria for ARVD/C (40% versus 18%), experience sustained ventricular arrhythmias (11% versus 1%), and die from a cardiac cause (2% versus 0%) than family members without mutations. Conclusions— Long-term outcome was favorable in diagnosed and treated ARVD/C index-patients and family members. Outcome in index-patients was modulated by implantable cardioverter-defibrillator implantation, but not by mutation status and familial background of disease. One third of family members developed ARVD/C. Outcome in family members was determined by symptoms at first evaluation and mutations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultArrhythmogenic Right Ventricular DysplasiaDeath, Sudden, CardiacDefibrillators, ImplantableDesmocollinsDesmoglein 2DesmoplakinsFemaleFollow-Up StudiesHumansKaplan-Meier EstimateMaleMiddle AgedPlakophilinsPolymorphism, Geneticgamma Catenin

Stichwörter der Autor:innen

arrhythmias, cardiacarrhythmogenic right ventricular dysplasiaarrhythmogenic right ventricular dysplasia-cardiomyopathycardiomyopathiesgenetics

Substanzen

DSC2 protein, humanDSG2 protein, humanDSP protein, humanDesmocollinsDesmoglein 2DesmoplakinsJUP protein, humanPKP2 protein, humanPlakophilinsgamma Catenin

Zitieren

APA

Groeneweg, J. A., Bhonsale, A., James, C. A., te Riele, A. S., Dooijes, D., Tichnell, C., Murray, B., Wiesfeld, A. C., Sawant, A. C., Kassamali, B., Atsma, D. E., Volders, P. G., de Groot, N. M., de Boer, K., Zimmerman, S. L., Kamel, I. R., van der Heijden, J. F., Russell, S. D., Jan Cramer, M., …, & Calkins, H. (2015). Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circulation: Cardiovascular Genetics, 8(3), 437-446. https://doi.org/10.1161/circgenetics.114.001003

Vancouver

Groeneweg JA, Bhonsale A, James CA, te Riele AS, Dooijes D, Tichnell C, et al. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circulation: Cardiovascular Genetics. 2015;8(3):437-446. doi:10.1161/circgenetics.114.001003

BibTeX
@article{Groeneweg2015,
  author = {Groeneweg, Judith A and Bhonsale, Aditya and James, Cynthia A and te Riele, Anneline S and Dooijes, Dennis and Tichnell, Crystal and Murray, Brittney and Wiesfeld, Ans C P and Sawant, Abhishek C and Kassamali, Bina and Atsma, Douwe E and Volders, Paul G and de Groot, Natasja M and de Boer, Karin and Zimmerman, Stefan L and Kamel, Ihab R and van der Heijden, Jeroen F and Russell, Stuart D and Jan Cramer, Maarten and Tedford, Ryan J and Doevendans, Pieter A and van Veen, Toon A and Tandri, Harikrishna and Wilde, Arthur A and Judge, Daniel P and van Tintelen, J Peter and Hauer, Richard N and Calkins, Hugh},
  title = {Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members},
  journal = {Circulation: Cardiovascular Genetics},
  year = {2015},
  volume = {8},
  number = {3},
  pages = {437--446},
  doi = {10.1161/circgenetics.114.001003}
}
Kostenlos starten →